Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation-Reference-Cited by-同舟云学术

Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation

Published:2019-03-18 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Wang Zhengqi,Vaughan Tamisha Y.,Zhu Wandi,Chen Yuhong,Fu Guoping,Medrzycki Magdalena,Nishio Hikaru,Bunting Silvia T.,Hankey-Giblin Pamela A.,Nusrat Asma,Parkos Charles A.,Wang Demin,Wen Renren,Bunting Kevin D.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference79 articles.

1. Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways;Murray;Nat Immunol.,2012

2. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice;Sellon;Infect Immun.,1998

3. The immunological and genetic basis of inflammatory bowel disease;Bouma;Nat Rev Immunol.,2003

4. Animal models of inflammatory bowel disease;Mizoguchi;Prog Mol Biol Transl Sci.,2012

5. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis;Lee;J Clin Invest.,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An analysis of the role of GAB2 in pan-cancer from a multidimensional perspective;Discover Oncology;2024-07-12

2. Target genes regulated by CLEC16A intronic region associated with common variable immunodeficiency;Journal of Allergy and Clinical Immunology;2024-06

3. Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets;Journal for ImmunoTherapy of Cancer;2023-05

4. Epithelial Gab1 calibrates RIPK3-dependent necroptosis to prevent intestinal inflammation;JCI Insight;2023-03-22

5. Identification of Grb2‐associated binding protein 3 expression to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma;Journal of Biochemical and Molecular Toxicology;2022-07-13